Learn More
Invitrogen™ LanthaScreen™ Tb-pERM (pLRRKtide) Antibody
A phospho specific antibody directed to the ezrin/radixin/moesin (ERM) peptide that is a substrate for LRRK2 (Leucine-rich repeat kinase 2) and LRRK2 mutants.
Brand: Invitrogen™ PV4897
Description
A phospho specific antibody directed to the ezrin/radixin/moesin (ERM) peptide that is a substrate for LRRK2 (Leucine-rich repeat kinase 2) and LRRK2 mutants. Mutations in LRRK2 have been found to be related to late-onset Parkinson's disease.
For use in combination with the Fluorescein-ERM (LRRKtide) substrate (Cat. No. PV4901) to evaluate inhibitors in medium to high throughput screening applications.
Specifications
| Serine/threonine kinase | |
| 0.52mg/mL | |
| 150kDa | |
| RUO | |
| Primary | |
| Terbium-labeled pERM (pLRRKtide) antibody in HEPES buffered saline. Store at -20°C. | |
| 340/490, 520 nm | |
| Dry Ice | |
| Hu | |
| LanthaScreen |
| Kinase Assay | |
| Tb (Terbium)/Lanthanide Chelates | |
| 25 μg | |
| Target and Lead Identification and Validation | |
| 1 Each | |
| Liquid | |
| Human | |
| End Point | |
| Ser/Thr Kinases |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
For Research Use Only. Not for use in diagnostic procedures.